Quarterly report · Q2
4078.TEDINET S100S5CT
Period2023-04-01 → 2023-09-30
Filed2023-11-08
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥40.5bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Revenue | ¥83.9bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥42.7bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Operating income | ¥917m | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Operating income | ¥3.3bn | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Ordinary income | ¥885m | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥4.6bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥3.8bn | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥773m | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥4.2bn | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥2.0bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.3bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥2.9bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥1.8bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Net income | ¥3.0bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Total assets | ¥131.6bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥128.0bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥128.4bn | at 2022-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥50.9bn | at 2023-09-30 | Cons. | Liabilities |
| Total liabilities | ¥43.3bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥80.7bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥84.7bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥85.8bn | at 2022-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥15.6bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥12.4bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥15.5bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥12.2bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥11.7bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥10.5bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥3.2bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥773m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.1bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥1.6bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.6bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.3bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥1.6bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥3.3bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥1.0bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-125.53 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-153.57 | 2023-07-01 → 2023-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥144.85 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥177.48 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥68.08 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 60.5% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 62.9% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 63.6% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-09-30 | −¥635m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-09-30 | −¥635m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-09-30 | −¥1.1bn |
| jpcrp040300-q2r_E00780-000Chemicalreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥36.8bn |
| jpcrp040300-q2r_E00780-000Chemicalreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥36.3bn |
| jpcrp040300-q2r_E00780-000Chemicalreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥498m |
| jpcrp040300-q2r_E00780-000Chemicalreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥1.9bn |
| jpcrp040300-q2r_E00780-000Medicine And Health Carereportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥4.3bn |
| jpcrp040300-q2r_E00780-000Medicine And Health Carereportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥4.2bn |
| jpcrp040300-q2r_E00780-000Medicine And Health Carereportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥136m |
| jpcrp040300-q2r_E00780-000Medicine And Health Carereportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥144m |
| —segment total | revenue | 2023-04-01 → 2023-09-30 | ¥41.1bn |
| —segment total | revenue external | 2023-04-01 → 2023-09-30 | ¥40.5bn |
| —segment total | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥635m |
| —segment total | segment profit | 2023-04-01 → 2023-09-30 | ¥2.0bn |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-09-30 | −¥860m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-09-30 | −¥860m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-09-30 | −¥1.1bn |
| jpcrp040300-q2r_E00780-000Chemicalreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥39.3bn |
| jpcrp040300-q2r_E00780-000Chemicalreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥38.6bn |
| jpcrp040300-q2r_E00780-000Chemicalreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥697m |
| jpcrp040300-q2r_E00780-000Chemicalreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥4.2bn |
| jpcrp040300-q2r_E00780-000Medicine And Health Carereportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥4.3bn |
| jpcrp040300-q2r_E00780-000Medicine And Health Carereportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥4.1bn |
| jpcrp040300-q2r_E00780-000Medicine And Health Carereportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥163m |
| jpcrp040300-q2r_E00780-000Medicine And Health Carereportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥240m |
| —segment total | revenue | 2022-04-01 → 2022-09-30 | ¥43.6bn |
| —segment total | revenue external | 2022-04-01 → 2022-09-30 | ¥42.7bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥860m |
| —segment total | segment profit | 2022-04-01 → 2022-09-30 | ¥4.4bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 522
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)有限責任 あずさ監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)三宅 潔 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)福島 康生 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 42694000000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 40471000000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 83861000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | 3830000000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | 885000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 4584000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | 2871000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | -2033000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 2344000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | 3666000000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | -542000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 3339000000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 85803000000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 80656000000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 84717000000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 128362000000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 131575000000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 128021000000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | 177.48 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | -125.53 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 144.85 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | － | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | － | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.636 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.605 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.629 | |
| Net cash provided by used in operating activities (5-year summary) | Prior1YTDDuration | 1122000000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | CurrentYTDDuration | 3187000000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | 773000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YTDDuration | -1285000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | CurrentYTDDuration | -1625000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -2620000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YTDDuration | 1006000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | CurrentYTDDuration | 1587000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | 3283000000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1QuarterInstant | 11667000000 | JPY |
| Cash and cash equivalents (5-year summary) | CurrentQuarterInstant | 15524000000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant | 12188000000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1QuarterDuration | 68.08 | |
| Basic earnings loss per share (5-year summary) | CurrentQuarterDuration | -153.57 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 17000000 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 17000000 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 17000000 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 17000000 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |